D-0862-2017 Class I Ongoing
FDA drug recall D-0862-2017 was initiated by Hospira Inc. on Apr 21, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter: human hair found within an internal sample syringe. The recall status is ongoing. Affected quantity: 71,550 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- May 31, 2017
- Initiation Date
- Apr 21, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 71,550 syringes
Product description
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10
Reason for recall
Presence of Particulate Matter: human hair found within an internal sample syringe.
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0862-2017
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.